These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8540181)

  • 21. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
    J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Galvanization of the area of the spleen as a method of immunocorrection in patients with chronic bronchitis].
    Siurin SA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (4):21-3. PubMed ID: 9424824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications.
    Fatourou EM; Koskinas JS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1499-510. PubMed ID: 19828011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neurosurgical complications of purulent meningitis in the tropical zone].
    Eholie SP; Boni N; Aoussi E; Konan A; Orega M; Koffi Adonis L; Ba Zeze V; Bissagnene E; Kadio A
    Neurochirurgie; 1999 Sep; 45(3):219-24. PubMed ID: 10567962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efferent methods in the therapy of puerperal and postoperative complications].
    Novikova ON; Orlov AB; Ushakova GA; Ivannikov NF; Popova NB
    Anesteziol Reanimatol; 2000; (3):52-4. PubMed ID: 10900723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adoptive immunotherapy methods in ENT oncology].
    Daĭkhes NA; Davudov KhSh
    Vestn Otorinolaringol; 1996; (1):35-8. PubMed ID: 8714051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunotherapy in complex treatment of surgical sepsis].
    Reshetnikov EA; Baranov GA; Chuvanov MV; Skalozub OI
    Khirurgiia (Mosk); 2008; (7):11-4. PubMed ID: 18833157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
    Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The combined rehabilitation of patients in the early and late periods after diskectomy].
    Miriutova NF; Levitskiĭ EF; Gorbunov FE; Abdulkina NG; Vel'bik IV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (3):28-31. PubMed ID: 10429569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour immunotherapy: the adjuvant treatment of the 21st century?
    Bremers AJ; Kuppen PJ; Parmiani G
    Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes.
    Pashov A; Monzavi-Karbassi B; Kieber-Emmons T
    Vaccine; 2009 May; 27(25-26):3405-15. PubMed ID: 19200843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy as a disease modifier.
    Martin JG; Shalaby K; Michoud MC
    Paediatr Respir Rev; 2006; 7 Suppl 1():S106-7. PubMed ID: 16798526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer.
    Rozková D; Tiserová H; Fucíková J; Last'ovicka J; Podrazil M; Ulcová H; Budínský V; Prausová J; Linke Z; Minárik I; Sedivá A; Spísek R; Bartůnková J
    Clin Immunol; 2009 Apr; 131(1):1-10. PubMed ID: 19201656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy.
    Velicu S; Han Y; Ulasov I; Brown IE; El Andaloussi A; Gajewski TF; Lesniak MS
    J Neuroimmunol; 2006 May; 174(1-2):74-81. PubMed ID: 16504307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in humoral and cellular immunity in patients operated on due to esophageal cancer].
    Szczesny T; Słotwiński R; Szczesny G
    Pol Merkur Lekarski; 2005 Apr; 18(106):478-82. PubMed ID: 16161939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunotropic treatment of patients with surgical treatment of the gastrointestinal tract].
    Maremkulov VKh; Razumovskiĭ AIu; Abidov MT; Alkhasov AB
    Khirurgiia (Mosk); 2005; (2):21-4. PubMed ID: 15803604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The strategy for immunotherapy in clinical neurological resuscitation].
    Starchenko AA; Khlunovskiĭ AN; Khil'ko VA; Prilukova TI
    Anesteziol Reanimatol; 1994; (2):64-7. PubMed ID: 8060005
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sulfidin therapy of traumatic meningitis and meningo-encephalitis].
    MIRONOVICH NI
    Vopr Neirokhir; 1945; 9(2):61. PubMed ID: 20277928
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of purulent meningitis and meningoencephalitis by infusion of sulfonamide preparations into the carotid after Burdenko].
    ROGOVOI IU
    Vopr Neirokhir; 1945; 9(2):22-7. PubMed ID: 20277916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.